UK: Total raised during 2023 for Apollo’s series C reached US$260m
Apollo Therapeutics, a portfolio biopharmaceutical company focused on translating fundamental medical research into medicines through a hub-and-spoke approach, completed a second close of its...
China: AstraZeneca to acquire Gracell Bio for up to US$1.2bn
Nasdaq-listed Gracell Biotechnologies, a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies for the treatment of cancers and autoimmune diseases,...
Investing in strength, building scale: outlook for European healthcare focused PE and VC investors
In November 2023, global management consultancy Arthur D Little (ADL) and Invest Europe’s European PE survey, combined with Invest Europe’s first half activity data,...
Germany: Schott Pharma prices IPO
Schott Pharma has priced its IPO at €27.00 per share. This corresponds to a placement volume of €935m (US$1.04bn) and a free float of...
InFocus: Creating value in non-therapeutic antibodies
Immunoassays, a non-therapeutic application of antibodies, have been a mainstay of diagnosis and research since the 1950s. Victor Chua, senior partner, and Will Johnson,...
InSight: Building the necessary infrastructure for psychedelics
As psychedelic assets move from development to commercialisation over the next five to ten years, the thousands of therapists and clinics required to deliver...
A strategic look at Asian healthcare M&A. Investors in Healthcare talks to Bain &...
Global healthcare M&A volumes dropped in 2022, but the long-term underlying drivers remain strong. Hopes are that deal activity will pick up through 2023....
InFocus: Mansfield Advisors examines opportunities for pharmaceuticals in women’s health
Women’s health encompasses more than gynaecology and obstetrics, but also includes specific treatments that support women to live full lives without discomfort, and special...
InSight: Don’t ignore the pharmaceutical industry in times of economic upheaval, says James Burt,...
The systemic importance of the life sciences sector is undeniable. In the US, four out of ten IPOs have been healthcare companies over the...
InFocus: Pharma goes faster with AI – L.E.K. Consulting
The application of Artificial Intelligence to the pharmaceutical industry is growing rapidly. Anne Dhulesia and Stephen Roper, partners at L.E.K. Consulting, building on in...
Advertisement
